Latest News

Researchers aim to assess the reliability of p-Tau217 in identifying early Alzheimer’s pathology and evaluate its potential as a scalable tool for long-term monitoring.

The expansion strategy also includes growing the group’s radiotherapy and advanced imaging services as demand for specialised healthcare rises across Egypt.

The leaders also pledged to protect essential services such as education, routine healthcare, cholera control and measles response efforts as countries confront the growing public health threat.

Liminatus went public in 2022 through a SPAC merger and initially highlighted several immune-modulating therapies originating from research collaborations in the United States and South Korea.

If approved, MAVIRET would become one of the few therapies in the European Union indicated for both acute and chronic HCV infection.

The product will be manufactured and commercialized to support treatment and prevention needs during influenza seasons, with an emphasis on improving availability for younger patients across China.

Through the new framework, WHO and AMA will coordinate efforts to streamline approval processes, enhance post-market surveillance, and build regulatory workforce capacity.

Wegovy® 7.2 mg is already available in the European Union for adults with obesity through three separate 2.4 mg injections administered weekly.

Once completed, the acquisition will integrate SPR’s technology into Medtronic’s broader pain management strategy, allowing the company to offer additional options for patients and clinicians seeking alternatives to drug-based therapies.

Fujifilm Cellular Dynamics will use the expanded site to produce its iCell product portfolio, which plays a key role in new approach methods (NAMs) used in modern drug discovery and toxicity testing.